                         SEQUENCE LISTING

<110>  Topas Therapeutics GmbH
 
<120>  Amphiphilic polymers and their use for improved production of 
       nanoparticles for the targeted delivery of antigens

<130>  P 107928

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide comprising T cell epitope

<400>  1

Leu Asn Ser Lys Ile Ala Phe Lys Ile Val Ser Gln Glu Pro Ala 
1               5                   10                  15  


<210>  2
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide comprising T cell epitope

<400>  2

Thr Pro Met Phe Leu Leu Ser Arg Asn Thr Gly Glu Val Arg Thr 
1               5                   10                  15  


<210>  3
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide comprising T cell epitope

<400>  3

Arg Glu Gly Ile Ala Phe Arg Pro Ala Ser Lys Thr Phe Thr Val 
1               5                   10                  15  


